Howard D. Beall

Affiliations: 
University of Montana, Missoula, MT 
Area:
Toxicology, Pharmaceutical Chemistry
Google:
"Howard Beall"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Weaver MJ, Stump S, Campbell MJ, et al. (2020) 10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence properties. Bioorganic & Medicinal Chemistry. 28: 115781
Stump S, Mou TC, Sprang SR, et al. (2018) Crystal structure of the major quadruplex formed in the promoter region of the human c-MYC oncogene. Plos One. 13: e0205584
Weaver MJ, Kearns AK, Stump S, et al. (2015) AIMing towards improved antitumor efficacy. Bioorganic & Medicinal Chemistry Letters. 25: 1765-70
Yilmaz A, Mohamed N, Patterson KA, et al. (2014) Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations. International Journal of Environmental Research and Public Health. 11: 9491-502
Duncan NS, Beall HD, Kearns AK, et al. (2014) Ethyl 3-(9-chloro-10-oxo-9,10-di-hydro-anthracen-9-yl)-5-methyl-isoxazole-4-carboxyl-ate. Acta Crystallographica. Section E, Structure Reports Online. 70: o315-6
Newsome JJ, Hassani M, Swann E, et al. (2013) Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1. Bioorganic & Medicinal Chemistry. 21: 2999-3009
Keyari CM, Kearns AK, Duncan NS, et al. (2013) Synthesis of new quinolinequinone derivatives and preliminary exploration of their cytotoxic properties. Journal of Medicinal Chemistry. 56: 3806-19
Mirzaei YR, Weaver MJ, Steiger SA, et al. (2012) Improved synthesis of 3-aryl isoxazoles containing fused aromatic rings. Tetrahedron. 68: 10360-10364
Kearns AK, Gajewski MP, Natale NR, et al. (2012) Abstract 1767: Anthracenyl isoxazole amides (AIMs) as novel agents for brain tumors Cancer Research. 72: 1767-1767
Cai W, Hassani M, Karki R, et al. (2010) Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents. Bioorganic & Medicinal Chemistry. 18: 1899-909
See more...